News releases of TVM Capital Life Science portfolio companies.

TVM Capital celebrates 30th Anniversary of Firm in Munich


Dr. Helmut Schühsler, Chairman and  Dr. Hubert Birner, Managing Partner together with around 120 guests from the international VC industry celebrated the firm’s 30th anniversary in Munich on July 24th. TVM Capital was one of the pioneers of the industry in Germany and Europe with a strong transatlantic investment focus on innovation-driven companies. Today the […]

Proteon Therapeutics Announces Publication of Results from Phase 2 Study of PRT-201

-Data in Journal of Vascular Surgery Demonstrate Potential to Improve Function and Durability of Vascular Access Required for Hemodialysis- WALTHAM, Mass. – May 14, 2014 – Proteon Therapeutics Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced the online […]

TVM Life Science Ventures VII Announces Investment in PRCL Research Inc.

Montréal, Québec, May 12th, 2014 –TVM Life Science Ventures VII today announced the fund’s fourth investment, a co-investment with the Fonds de solidarité FTQ (the “Fonds”) – establishing PRCL Research Inc., a company based in Montréal, Québec. PRCL Research Inc. plans to develop, to proof-of-concept, a compound originally discovered by Synta Pharmaceuticals Inc. with the […]

invendo medical closes € 20M equity capital funding led by Xeraya Capital

Significant financing to accelerate industrialization and commercialization of invendo’s single-use colonoscope – Kissing, Germany – Garden City, NY — March 20, 2014 — invendo medical, manufacturer and distributor of a single-use and computer-assisted colonoscopy system, today announced the closing of a € 20.3 million ($ 28 million) financing round led by new investor Xeraya Capital […]

TVM Capital Life Science counts two successful biotech IPOs of portfolio in the U.S. market in the last two weeks – which brings the total to four IPOs within 10 months, raising $ 300 million


Munich, Montreal,  February 19, 2014 — Biotech IPOs continue to roll on and it is an explicit pleasure for TVM Capital Life Science as an investor to be part of the now year-long biotech IPO boom on NASDAQ  which is one of the busiest IPO period in the history of U.S. biotech. Only a few […]